Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and the Company’s Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities, Everest Organics has informed that the trading window for dealing in Securities of the Company shall remain closed from July 01, 2025 until 48 hours after the declaration of Un-audited Financial Results for the Quarter ended June 30, 2025 for all the Directors, Promoters, Designated Employees, Persons and Specified Connected Persons of the Company and to their immediate relatives. The date of Board Meeting of the Company for consideration and approval of the Un-audited Financial Results for the Quarter ended June 30, 2025 will be intimated later.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1693.15 |
| Dr. Reddys Lab | 1221.25 |
| Cipla | 1230.75 |
| Zydus Lifesciences | 939.20 |
| Lupin | 2326.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: